CONDUIT PHARMACEUTICALS
(NASDAQ: CDT)

Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.

0.075

+0.009 (+13.64%)
Range 0.062 - 0.076   (22.58%)
Open 0.062
Previous Close 0.066
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 18,337,113
Value -
Remark
Delayed prices. Updated at 21 Dec 2024 05:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis